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Responsiveness of researchers is as important as responsiveness
of study participantsIf clinical research is to have impact on decision making
in health care, responsiveness is a key principle in he broad-
est sense of the word. That is, researchers should be able to
connect their own perspective with that of patients, clini-
cians, and policy makers [1].
Can the scientific community be responsive to the need
of decision makers to have evidence timely available, suf-
ficiently tailored to answer their specific questions? Based
on a literature review and interviews with organizations
producing rapid reviews or related products to meet this
need, Hartling et al. examined characteristics of rapid
products and the impact of methodological variations on
their reliability and validity. Based on extent of synthesis,
they classified rapid products in inventories, rapid re-
sponses, rapid reviews, and automated approaches.
According to the authors, rapid products have to be
prepared in a very different context than standard system-
atic reviews and have tremendous methodological varia-
tion, and there is little empiric evidence on the validity
of their results and conclusions. They discuss require-
ments for useful rapid products in relation to the nature
of the decision and the relationship with the end user, to
meet time-sensitive decision making needs. In a commen-
tary to the work of Hartling c.s, Welch and colleagues
propose to classify rapid products also accross two addi-
tional domains: type of producer, and methods for contex-
tualizing evidence to a particular decision. Furthermore,
they recommend to assess the utility and impact of rapid
review products from the patient perspective. Both groups
emphasize the need to consider the trade-offs between
timeliness, appropriateness, utility, comprehensiveness
and rigor.
Researchers also need to be responsive to meet specific
methodological problems. White and his group point out
that, while respondent-driven sampling (RDS) has been
developed to solve sampling challenges in hard-to-reach
groupsee.g., in estimating HIV prevalence in drug users -
RDS reporting quality and available reporting guidelines
are inadequate. Therefore, based on a systematic review
of RDS studies, they developed a checklist of essential
items that should be reported in RDS publications. They
present these items as STROBE-RDS (Strengthening the
Reporting of Observational Studies in Epidemiology for
RDS studies). The authors expect that, if widely adopted,http://dx.doi.org/10.1016/j.jclinepi.2015.10.008
0895-4356/ 2015 Elsevier Inc. This is an open access article under the CC BSTROBE-RDS should improve public health decision
making in infectious diseases.
One of the most important ways in which patients can be
responsive to a study is in giving informed consent (IC) to
participate. As this is not an easy decision, IC documents
must meet high standards. In a review of IC documents,
Brehaut and his team evaluated to what extent such docu-
ments, for trials registered with ClinicalTrials.gov, conform
to IC standards, and also assessed how well conformity to
decision quality (DQ) standards can be predicted by IC
standards. They found a relatively high but variable con-
formity to recommendations for improving IC, and this
conformity was only moderately related to whether the IC
document conformed to recommendations for improving
DQ. The authors conclude that existing IC regulations
may not describe the optimal approach to helping people
in making study participation decisions.
Conducting valid cohort studies needs responsive study
participants to achieve the required follow-up. This requires
effective retention strategies, with the researchers being re-
ponsive in identifying themes that are crucial for partici-
pants to cooperate. Robinson and co-workers updated
their prior systematic review to assess retention strategies
for follow-up [2]. They found a substantial increase in stud-
ies reporting retention strategies. While lack of comparative
studies and between- study heterogeneity made it difficult
to determine which strategies were most effective, using a
larger number of strategies in one study appears to enhance
participant retention. These authors recommend to better
assess the efficacy of retention strategies. Clark and co-
authors report an effectiveness study focusing on one
specific strategyesending electronic prompts - to reduce
attrition among participants in a trial on the effectiveness
on chronic obstructive pulmonary disease screening on
smoking cessation (‘a trial within a trial’). They combined
their results with two previous studies in a meta-analysis
and found that electronic prompts, by phone or email,
increased response rates and reduced the time to response.
Another element of responsiveness that clinical
researchers can only appropiately address when they are re-
sponsive themselves, in this case to patient perceptions and
experiences, is the minimal important change (MIC) of
health-related quality of life scales. In this context,
Terluin et al. present a new method based on predictiveY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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MIC is the change score associated with a likelihood ratio
of 1, with the posttest probability being equal to the pretest
probability. In this context they refer to diagnostic research
(in which, by the way, an analogous approach has been de-
veloped [3]). Simulation studies demonstrated that in many
situations the new method yields the same value as the
ROC-based MIC but is more precise. In addition, the new
method offers the opportunity to evaluate possible modify-
ing variables such as baseline scores.
Hopewell c.s. evaluated the publication and quality of
reporting of abstracts of systematic reviews presented at
scientific medical conferences, using proceedings of lead-
ing international conferences in 2010. They found that less
than 1% of all conference abstracts reported systematic re-
view findings, of which only half were published in full ar-
ticles. Moreover, there were serious deficiencies in the
reporting of abstracts, and important discrepancies between
conference and journal abstracts. The authors recommend
that editors and conference organizers actively implement
Preferred Reporting Items for Systematic reviews and
Meta-analysis (PRISMA) guidance for reporting abstracts
of systematic reviews. The reporting of abstracts and full
papers on cross-over trials in chronic pain conditions was
systematically reviewed Straube et al. While features such
as double blind status and randomised allocation were com-
monly included in abstracts and full journal publications,
important shortcomings in reporting were found for adverse
events (in abstracts) and for specification of results by
crossover period (in full texts). Also these authors make a
plea for better reporting. According to Papageorgiou c.s.
the reporting of the study design in orthodontics should
be improved. Based on a (first) meta-epidemiological
study to identify bias in clinical trials in orthodontics, they
conclude that systematic reviews on clinical orthodontic
interventions must be interpreted with caution when non-
randomized, especially retrospective studies, are included.
Good reporting should go hand-in-hand with appropriate
analysis. Jones and co-workers compared five methods us-
ing Cox regression in the analysis of a stratified case-cohort
study to estimate the association between physical activity
and incident type 2 diabetes. They concluded that the most
flexible model, a stage 2 Cox model with random effects
meta-analysis, making fewer assumptions than the other
models, gave the most reliable results and should be rou-
tinely considered for analyzing stratified case-cohort stud-
ies. An exception may be when there are very few events
or strata. Kahan and Harhay reviewed the number of pa-
tients and (often few) events per center and the methods
of analysis in multicenter trials. The authors recommend
adjustment for center using random-effects models or gen-
eralized estimating equations (GEEs) with model-based
standard errors, which were rarely used in the reviewed
studies. Wynants et al. give guidance for dealing with data
from different centers when developing prediction models.
To study the effect of the number of events per variable(EPV) in prediction modeling with clustered data, they used
simulated data and an empirical example (the classification
of ovarian tumor). It was found that, using multilevel logis-
tic regression, EPV can be used to guide sample size deci-
sions in clustered data. The authors recommend to have at
least 10 EPV for predefined models, although 50 may be
needed when performing variable selection. The selecting
of variables was also studied by Caruana cs., who propose
a procedure to select the minimum set of variables to be in-
cluded in a propensity score analysis of observational data.
They introduced a new weighted summary balance measure
that takes into account strength of association of each cova-
riate with the outcome, and used simulated data followed
by application to real data (from a cohort study of decom-
pensated heart failure patients). They conclude that a bal-
ance measure as proposed may help to identify the most
parsimonious PS model.
Also in studying adverse drug reactions (ADRs), appro-
priate analysis of observational data is essential. In an ex-
ploratory study using a cohort of diabetes patients, Scholl
and his group investigated whether the time to onset of
common ADRs of antidiabetic drugs could be modeled us-
ing parametric distributions. They found that for the gamma
or Weibull distribution this was indeed the case, and that
this approach can also provide useful information for clin-
ical decision making.
As the proportion of cases registered by death certifi-
cates only (DCO) is a common indicator for potential bias
in cancer survival studies, Brenner and Jansen investigated
whether reported DCO proportions should be restricted to
the specific recent calender period (restricted period) or
should refer to all years of diagnosis of included patients
(full period). Using cancer registry data combined with
simulated patterns of underreporting of deceased cases,
the authors concluded that the DCO proportions derived
for the restricted period are a better indicator of potential
bias than DCO proportions for the full period. This finding
is relevant for future cancer survival reports.
To what extent will published papers be used and cited,
also after many years? Perneger examined whether early
online access to medical research articles has predictive
value for citations over time. Based on a cohort study of
BMJ articles, he found that online access in the first week
after publication predicts citations up to 15 years later. The
author suggests that the number of internet accesses may be
a useful early indicator of scientific value, but before rec-
ommending it for use, confirmation of its properties in other
contexts is desirable.
Publishing research may have impact by helping
excellent groups in different parts of the world finding
one another working at similar new developments. In
connection to a previous article of Schlattmann et al. [4],
the groups of Eusebi and Schlattmann discuss the chal-
lenges related to mixture models for diagnostic meta-
analysis and the potentials of generalized latent variable
modeling. In a communication following on a paper by
1387Editorial / Journal of Clinical Epidemiology 68 (2015) 1385e1387Bello et al. [5], Hemil€a and Bello & Hrobjartsson discuss
an example used in that paper - zinc lozenges and
vitamin C for the common cold e, clarifying concepts as
placebo, (un) blinding, and mechanisms of bias.
Last but not least, highly appreciated achievements have
to highlighted.
Published high quality research requires high quality re-
views of submitted manuscripts. The editorial team is there-
fore extremely grateful to our reviewers, who helped us to
make editorial decisions and to safeguard the quality of the
papers published in the past year. Their names are
mentioned in this issue. In addition, at our annual editorial
retreat, two outstanding reviewers were selected to receive
the annual JCE Reviewer Award: Dr. Quan Nha Hong and
Dr. Amand Floriaan Schmidt. More information about
these reviewers is presented in this issue.
In 2015, the Journal of Clinical of Epidemiology has in-
itiated an annual young investigator award. This award is
named to celebrate the memory of the late David L.Sackett,
who over many decades and in numerous ways has inspired
and educated generations of young investigators in clinical
epidemiology and evidence-based medicine. The David
Sackett Young Investigator Award is to recognize outstand-
ing papers by young researchers that exemplify the values
of creativity and scientific excellence. From many nomina-
tions received, the editorial team and its advisers have
selected Dr. David van Klaveren - first author of the article
‘‘Estimates of absolute treatment benefit for individual pa-
tients required careful modeling of statistical interactions’’[6] - as the first winner of the award. In this issue you will
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